APA (7th ed.) Citation

Wang, J., Zhu, H., & Miao, K. (2024). Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation. Annals of Hematology, 103(5), 1775. https://doi.org/10.1007/s00277-024-05714-y

Chicago Style (17th ed.) Citation

Wang, Jiawen, Han Zhu, and Kourong Miao. "Gilteritinib Combined with Venetoclax and Azacitidine for Relapsed Acute Myeloid Leukemia Cocurrent with Pure Red Cell Aplasia After Allogeneic Hematopoietic Stem Cell Transplantation." Annals of Hematology 103, no. 5 (2024): 1775. https://doi.org/10.1007/s00277-024-05714-y.

MLA (9th ed.) Citation

Wang, Jiawen, et al. "Gilteritinib Combined with Venetoclax and Azacitidine for Relapsed Acute Myeloid Leukemia Cocurrent with Pure Red Cell Aplasia After Allogeneic Hematopoietic Stem Cell Transplantation." Annals of Hematology, vol. 103, no. 5, 2024, p. 1775, https://doi.org/10.1007/s00277-024-05714-y.